GLP1R in Parkinson's Disease

NCT03659682 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Semaglutide

Sponsor

Oslo University Hospital